NO20025805L - Farmasöytisk preparat - Google Patents

Farmasöytisk preparat

Info

Publication number: NO20025805L
Authority: NO; Norway
Prior art keywords: pharmaceutical preparation; pharmaceutical; preparation
Prior art date: 2001-12-05

Application number

NO20025805A

Other languages

English (en)

Other versions

NO20025805D0 (no

NO329896B1 (no

Inventor

Robert William Baker

Alan David Dow

Simon John Summers

Julian Westrup

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-05

Filing date

2002-12-03

Publication date

2003-06-06

2002-12-03 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2002-12-03 Publication of NO20025805D0 publication Critical patent/NO20025805D0/no

2003-06-06 Publication of NO20025805L publication Critical patent/NO20025805L/no

2011-01-24 Publication of NO329896B1 publication Critical patent/NO329896B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20025805A 2001-12-05 2002-12-03 Farmasoytisk sammensetning og anvendelse derav NO329896B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0129117.8A GB0129117D0 (en)	2001-12-05	2001-12-05	Pharmaceutical composition

Publications (3)

Publication Number	Publication Date
NO20025805D0 NO20025805D0 (no)	2002-12-03
NO20025805L true NO20025805L (no)	2003-06-06
NO329896B1 NO329896B1 (no)	2011-01-24

Family

ID=9927051

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20025805A NO329896B1 (no)	2001-12-05	2002-12-03	Farmasoytisk sammensetning og anvendelse derav

Country Status (28)

Country	Link
US (1)	US20050032867A1 (no)
EP (2)	EP1450770B1 (no)
JP (1)	JP3699969B2 (no)
KR (1)	KR100591237B1 (no)
CN (1)	CN1289069C (no)
AR (1)	AR037627A1 (no)
AT (1)	ATE291900T1 (no)
AU (1)	AU2002358602B2 (no)
BR (1)	BR0214497A (no)
CA (1)	CA2469019C (no)
CO (1)	CO5580741A2 (no)
DE (1)	DE60203537T2 (no)
ES (1)	ES2236608T3 (no)
FI (1)	FI20022128A7 (no)
GB (1)	GB0129117D0 (no)
HU (1)	HU229313B1 (no)
IL (1)	IL161997A (no)
IS (1)	IS2481B (no)
MX (1)	MXPA04005420A (no)
MY (1)	MY129314A (no)
NO (1)	NO329896B1 (no)
NZ (1)	NZ532829A (no)
PL (1)	PL194702B1 (no)
PT (1)	PT1450770E (no)
RU (1)	RU2285526C2 (no)
TW (1)	TWI240638B (no)
WO (1)	WO2003047552A2 (no)
ZA (1)	ZA200403849B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8071128B2 (en)	1996-06-14	2011-12-06	Kyowa Hakko Kirin Co., Ltd.	Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en)	2001-10-04	2016-06-07	Adare Pharmaceuticals, Inc.	Timed, sustained release systems for propranolol
US8367111B2 (en)	2002-12-31	2013-02-05	Aptalis Pharmatech, Inc.	Extended release dosage forms of propranolol hydrochloride
JP2006522790A (ja) *	2003-04-11	2006-10-05	ファイザー・インク	エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物
BRPI0410807A (pt) *	2003-06-06	2006-06-27	Glaxo Group Ltd	composição farmacêutica, e, método pata tratar um mamìfero sofrendo de ou susceptìvel a condições associadas com dor cefálica
WO2005115345A1 (en) *	2004-05-28	2005-12-08	Imaginot Pty Ltd	Oral therapeutic compound delivery system
US8216610B2 (en) *	2004-05-28	2012-07-10	Imaginot Pty Ltd.	Oral paracetamol formulations
US8747895B2 (en)	2004-09-13	2014-06-10	Aptalis Pharmatech, Inc.	Orally disintegrating tablets of atomoxetine
US9884014B2 (en)	2004-10-12	2018-02-06	Adare Pharmaceuticals, Inc.	Taste-masked pharmaceutical compositions
WO2006047493A2 (en)	2004-10-21	2006-05-04	Eurand Pharmaceuticals Limited	Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en)	2005-05-02	2015-10-20	Adare Pharmaceuticals, Inc.	Timed, pulsatile release systems
WO2007059591A1 (en)	2005-11-28	2007-05-31	Imaginot Pty Ltd	Oral therapeutic compound delivery system
RU2313340C1 (ru) *	2006-02-20	2007-12-27	Дмитрий Владимирович Зимин	Лекарственное средство, обладающее противомигренозным действием, и способ его изготовления
WO2007130373A2 (en) *	2006-05-01	2007-11-15	Capricorn Pharma, Inc.	Novel triptan formulations and methods for making them
WO2008039358A2 (en) *	2006-09-30	2008-04-03	Capricorn Pharma Inc.	Resin-complex granulation for water-soluble drugs and associated methods
RU2424803C2 (ru) *	2008-04-07	2011-07-27	Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии имени В.В. Закусова РАМН (НИИ фармакологии имени В.В.Закусова РАМН)	Фармацевтическая композиция с противомигреневым действием (варианты)
MX2012006240A (es)	2009-12-02	2012-10-03	Aptalis Pharma Ltd	Microcapsulas de fexofenadina y composiciones que contienen las mismas.
US11364225B2 (en)	2019-08-21	2022-06-21	Bn Intellectual Properties, Inc.	Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same
IL297218A (en) *	2020-04-24	2022-12-01	Astrazeneca Ab	Pharmaceutical formulations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9027827D0 (en) *	1990-12-21	1991-02-13	Glaxo Laboratoires	Pharmaceutical compositions
US5468504A (en) *	1990-12-21	1995-11-21	Laboratoires Glaxo S.A.	Effervescent pharmaceutical compositions
GB9104890D0 (en) *	1991-03-08	1991-04-24	Glaxo Group Ltd	Compositions
US5460972A (en) *	1991-04-08	1995-10-24	Research Foundation Of The State University Of New York	Ionized magnesium2+ concentrations in biological samples
US6649186B1 (en) *	1996-09-20	2003-11-18	Ethypharm	Effervescent granules and methods for their preparation
GB9704524D0 (en) *	1997-03-05	1997-04-23	Smithkline Beecham Plc	Composition
GB9706089D0 (en) *	1997-03-24	1997-05-14	Scherer Ltd R P	Pharmaceutical composition
WO1999043306A1 (en) *	1998-02-26	1999-09-02	Banyu Pharmaceutical Co., Ltd.	An orally disintegrating composition and its manufacturing method
US6350470B1 (en) *	1998-04-29	2002-02-26	Cima Labs Inc.	Effervescent drug delivery system for oral administration
US6383471B1 (en) *	1999-04-06	2002-05-07	Lipocine, Inc.	Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6264981B1 (en) *	1999-10-27	2001-07-24	Anesta Corporation	Oral transmucosal drug dosage using solid solution
CA2392810A1 (en) *	1999-12-01	2001-06-07	Natco Pharma Limited	A rapid acting freeze dired oral pharmaceutical composition for treating migraine
KR20010107754A (ko) *	2000-05-26	2001-12-07	민경윤	경구투여용 속용정의 제조 방법
US20030008005A1 (en) *	2001-07-05	2003-01-09	R.T. Alamo Ventures, Inc.	Sublingual administration of dihydroergotamine for the treatment of migraine

2001
- 2001-12-05 GB GBGB0129117.8A patent/GB0129117D0/en not_active Ceased
2002
- 2002-12-03 AR ARP020104674A patent/AR037627A1/es unknown
- 2002-12-03 MY MYPI20024534A patent/MY129314A/en unknown
- 2002-12-03 FI FI20022128A patent/FI20022128A7/fi not_active Application Discontinuation
- 2002-12-03 TW TW091134979A patent/TWI240638B/zh not_active IP Right Cessation
- 2002-12-03 NO NO20025805A patent/NO329896B1/no not_active IP Right Cessation
- 2002-12-04 IL IL16199702A patent/IL161997A/xx active IP Right Grant
- 2002-12-04 RU RU2004120292/15A patent/RU2285526C2/ru not_active IP Right Cessation
- 2002-12-04 ES ES02792887T patent/ES2236608T3/es not_active Expired - Lifetime
- 2002-12-04 WO PCT/EP2002/013715 patent/WO2003047552A2/en not_active Ceased
- 2002-12-04 AT AT02792887T patent/ATE291900T1/de active
- 2002-12-04 PL PL02370669A patent/PL194702B1/pl unknown
- 2002-12-04 AU AU2002358602A patent/AU2002358602B2/en not_active Expired
- 2002-12-04 DE DE60203537T patent/DE60203537T2/de not_active Expired - Lifetime
- 2002-12-04 CN CNB028244184A patent/CN1289069C/zh not_active Expired - Fee Related
- 2002-12-04 CA CA002469019A patent/CA2469019C/en not_active Expired - Lifetime
- 2002-12-04 US US10/497,749 patent/US20050032867A1/en not_active Abandoned
- 2002-12-04 JP JP2003548808A patent/JP3699969B2/ja not_active Expired - Lifetime
- 2002-12-04 PT PT02792887T patent/PT1450770E/pt unknown
- 2002-12-04 EP EP02792887A patent/EP1450770B1/en not_active Expired - Lifetime
- 2002-12-04 KR KR1020047008687A patent/KR100591237B1/ko not_active Expired - Lifetime
- 2002-12-04 BR BR0214497-2A patent/BR0214497A/pt not_active Application Discontinuation
- 2002-12-04 MX MXPA04005420A patent/MXPA04005420A/es active IP Right Grant
- 2002-12-04 HU HU0402178A patent/HU229313B1/hu unknown
- 2002-12-04 NZ NZ532829A patent/NZ532829A/en not_active IP Right Cessation
- 2002-12-04 EP EP05075288A patent/EP1527773A1/en not_active Withdrawn
2004
- 2004-05-19 ZA ZA2004/03849A patent/ZA200403849B/en unknown
- 2004-06-03 CO CO04052110A patent/CO5580741A2/es active IP Right Grant
- 2004-06-03 IS IS7293A patent/IS2481B/is unknown

Also Published As

Publication number	Publication date
JP2005515991A (ja)	2005-06-02
GB0129117D0 (en)	2002-01-23
CA2469019A1 (en)	2003-06-12
EP1450770A2 (en)	2004-09-01
ZA200403849B (en)	2005-10-26
ATE291900T1 (de)	2005-04-15
IS7293A (is)	2004-06-03
AU2002358602A1 (en)	2003-06-17
NO20025805D0 (no)	2002-12-03
EP1450770B1 (en)	2005-03-30
IS2481B (is)	2008-12-15
FI20022128L (fi)	2003-06-06
FI20022128A7 (fi)	2003-06-06
EP1527773A1 (en)	2005-05-04
WO2003047552A2 (en)	2003-06-12
JP3699969B2 (ja)	2005-09-28
DE60203537T2 (de)	2005-09-15
PL194702B1 (pl)	2007-06-29
US20050032867A1 (en)	2005-02-10
PT1450770E (pt)	2005-08-31
CO5580741A2 (es)	2005-11-30
RU2285526C2 (ru)	2006-10-20
CA2469019C (en)	2005-09-13
HK1069111A1 (en)	2005-05-13
MY129314A (en)	2007-03-30
IL161997A (en)	2005-12-18
WO2003047552A3 (en)	2003-09-25
TW200304384A (en)	2003-10-01
HUP0402178A3 (en)	2011-05-30
RU2004120292A (ru)	2005-04-10
KR100591237B1 (ko)	2006-06-19
ES2236608T3 (es)	2005-07-16
AR037627A1 (es)	2004-11-17
NO329896B1 (no)	2011-01-24
DE60203537D1 (de)	2005-05-04
KR20050044720A (ko)	2005-05-12
PL370669A1 (en)	2005-05-30
HU229313B1 (en)	2013-10-28
HUP0402178A2 (hu)	2005-02-28
IL161997A0 (en)	2005-11-20
AU2002358602B2 (en)	2005-05-26
NZ532829A (en)	2005-05-27
TWI240638B (en)	2005-10-01
BR0214497A (pt)	2004-10-19
MXPA04005420A (es)	2004-10-11
CN1610539A (zh)	2005-04-27
FI20022128A0 (fi)	2002-12-03
CN1289069C (zh)	2006-12-13

Publication	Publication Date	Title
NO20033143D0 (no)	2003-07-09	Farmasoytisk preparat
NO20030418D0 (no)	2003-01-27	Nytt farmasöytisk preparat
NO20034026D0 (no)	2003-09-11	Nytt preparat
NO20035208D0 (no)	2003-11-24	Nytt vaksine preparat
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
EE200300416A (et)	2003-12-15	Ravimvorm
PL367180A1 (pl)	2005-02-21	Trwała kompozycja farmaceutyczna
NO20033042L (no)	2003-09-04	Cyklodekstrin-inneholdende farmasöytisk preparat
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
NO20035315D0 (no)	2003-11-28	Farmasöytiske kombinasjoner
NO20025805L (no)	2003-06-06	Farmasöytisk preparat
NO20034695L (no)	2003-12-03	Nytt preparat
NO20015149L (no)	2001-12-17	Nytt farmasöytisk preparat
NO20015148D0 (no)	2001-10-22	Nytt farmasöytisk preparat
NO20015104D0 (no)	2001-10-19	Nytt farmasöytisk preparat
NO20015105D0 (no)	2001-10-19	Nytt farmasöytisk preparat
NO20023392L (no)	2002-09-16	Preparat
NO20021036L (no)	2002-04-26	Farmasöytisk preparat
NO20041236L (no)	2004-03-24	Farmasoytisk formulering
SE0103565D0 (sv)	2001-10-25	Pharmaceutical formulation
SE0101171D0 (sv)	2001-04-02	Pharmaceutical formulation
SE0101325D0 (sv)	2001-04-12	Pharmaceutical formulation
SE0101326D0 (sv)	2001-04-12	Pharmaceutical formulation
SE0102957D0 (sv)	2001-09-04	Pharmaceutical formulation

Legal Events

Date	Code	Title	Description
2013-05-21	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: GLAXO GROUP LTD, GB
2023-01-09	MK1K	Patent expired